Paediatric

15 registered clinical trials studyying Paediatric — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Vegetarian Tube Feed Study NCT07378111	Société des Produits Nestlé (SPN)	N/A
Enrolling By Invitation	Innovative Probe With Laser on Radial Artery Puncture and Catheterisation in Paediatric NCT07454005	The First Hospital of Jilin University	N/A
Not Yet Recruiting	BELUGA: Better to Exchange ETT for LMA Before Extubation in Children Under General Anaesthesia NCT07204990	Telethon Kids Institute	N/A
Recruiting	Infrared Thermography for Prediction of Successful Erector Spinae Plane Block in Unilateral Inguinal Hernia Su NCT07161375	Cairo University	—
Completed	Analgesia Evaluation of an Ultrasound-guided Technique for Inguinal Hernia Surgery in Children in Children NCT06883370	National University of Malaysia	Phase 4
Completed	Using Immersive Virtual Reality for Children's Lower Limb Rehabilitation NCT05274152	Sheffield Hallam University	N/A
Recruiting	Nutrition in Paediatric Critical Care NCT06695078	Australian and New Zealand Intensive Care Research Centre	—
Completed	Erector Spinae Plane Block for Paediatric Upper Abdominal Surgery NCT04518215	Nazmy Edward Seif	N/A
Completed	Comparison of Efficacy of Little Lovely Dentist, Dental Song and Tell-show-do Techniques in Alleviating Dental NCT04833478	Altamash Institute of Dental Medicine	N/A
Completed	Using Virtual Reality for Rehabilitation of Upper Limbs at Home Trial NCT05272436	Sheffield Hallam University	N/A
Completed	Erector Spinae Plane Block Versus Fentanyl Infusion in Pediatric Patients Undergoing Aortic Coarcitectomy NCT04128540	Cairo University	Phase 3
Completed	Comparative Study Between Zirconia Crowns and Endocrowns in Pulpotomized Primary Molars NCT04073901	Nahda University	N/A
Terminated	Dose-finding Study of MCI-196 NCT01814904	Tanabe Pharma Corporation	Phase 3
Terminated	Safety and Tolerability Study of MCI-196 NCT01818687	Tanabe Pharma Corporation	Phase 3
Terminated	Long-term Extension Study of MCI-196 NCT01814917	Tanabe Pharma Corporation	Phase 3